Yevgeniy Khariton

Yevgeniy Khariton

University of Missouri - Kansas City - Kansas City / United States
Medical and Health Sciences / Cardiology
AD Scientific Index ID: 4658977
-
person_outline Yevgeniy Khariton's MOST POPULAR ARTICLES
1-) The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trialME Nassif, SL Windsor, BA Borlaug, DW Kitzman, SJ Shah, F Tang, ...Nature medicine 27 (11), 1954-1960, 20213642021
2-) Dapagliflozin effects on biomarkers, symptoms, and functional status in patients with heart failure with reduced ejection fraction: the DEFINE-HF trialME Nassif, SL Windsor, F Tang, Y Khariton, M Husain, SE Inzucchi, ...Circulation 140 (18), 1463-1476, 20193642019
3-) Association of Serial Kansas City Cardiomyopathy Questionnaire Assessments With Death and Hospitalization in Patients With Heart Failure With Preserved and Reduced Ejection …SJA Pokharel Y, Khariton Y, Tang Y, Nassif ME, Chan PS, Arnold SV, Jones PGJAMA: Cardiology, 2017982017
4-) Target doses of heart failure medical therapy and blood pressure: insights from the CHAMP-HF registryPA Peri-Okonny, X Mi, Y Khariton, KK Patel, L Thomas, GC Fonarow, ...JACC: Heart Failure 7 (4), 350-358, 20191042019
5-) Health status disparities by sex, race/ethnicity, and socioeconomic status in outpatients with heart failureY Khariton, ME Nassif, L Thomas, GC Fonarow, X Mi, AD DeVore, C Duffy, ...JACC: Heart Failure 6 (6), 465-473, 20181022018